✦ LIBER ✦

Phase II Study of Weekly Docetaxel Alone or in Combination with Trastuzumab in Patients with Metastatic Breast Cancer

✍ Scribed by Joshua P. Raff; Lakshmi Rajdev; Umekalsoom Malik; Yelena Novik; Jane M. Manalo; Abdissa Negassa; Una Hopkins; Catherine Sarta; Joseph A. Sparano

Book ID: 119934699
Publisher: CIG Media Group, LP.
Year: 2004
Tongue: English
Weight: 126 KB
Volume: 4
Category: Article
ISSN: 1526-8209
DOI: 10.3816/cbc.2004.n.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Study of Weekly Docetaxel and C

Phase II Study of Weekly Docetaxel and Capecitabine in Patients with Metastatic Breast Cancer

✍ Ewa Mrozek; Bhuvaneswari Ramaswamy; Donn Young; Chris A. Rhoades; Kari Kendra; J 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 111 KB

A phase II trial of weekly docetaxel and

A phase II trial of weekly docetaxel and trastuzumab in metastatic breast cancer

✍ A. Taran; K. Wollschlaeger; B. Bliimel; E. Kettner; S.D. Costa; J. Bischoff 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 68 KB

A phase II study of weekly docetaxel in

A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer

✍ Hugo E. R. Ford; Yoon-Sim Yap; David W. Miles; Andreas Makris; Marcia Hall; Liz 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 311 KB

A phase 1 study of weekly everolimus (RA

A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer

✍ Stacy Moulder; Gregory Gladish; Joe Ensor; Ana Maria Gonzalez-Angulo; Massimo Cr 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 827 KB

Phase II studies on docetaxel alone ever

Phase II studies on docetaxel alone every third week, or weekly in combination with gemcitabine in patients with primary locally advanced, metastatic, or recurrent esophageal cancer

✍ M. Albertsson; B. Johansson; S. Friesland; L. Kadar; H. Letocha; G. Frykholm; G. 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 133 KB

A Phase II study of bevacizumab in combi

A Phase II study of bevacizumab in combination with trastuzumab and docetaxel in HER2 positive metastatic breast cancer

✍ Zhao, Meng; Pan, Xueliang; Layman, Rachel; Lustberg, Maryam B.; Mrozek, Ewa; Mac 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 403 KB